Real-world study tests migraine drug atogepant over 12 months in tough-to-treat patients
NCT ID NCT07699549
First seen Jul 13, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study follows over 500 adults with migraine who have not responded well to other preventive treatments. Participants take atogepant as prescribed by their doctor and are monitored for a year to see how well it reduces headache and migraine days, and how long they stay on the medication. The goal is to understand if atogepant works in everyday clinical practice for people with a high burden of migraine.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- atogepant
- What this could lead to
- If successful, this could confirm atogepant as a reliable long-term preventive option for people with hard-to-treat migraine.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by patient selection and real-world variability. It is also limited to a specific population with prior treatment failures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEADACHE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario de La Princesa
Madrid, Madrid, 28006, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a quick neck adjustment change deep headache muscles?
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?
- Experimental migraine drug JS010 takes first step in human safety trial
- Scientists probe shared pain pathways in endometriosis and migraine
- Brain scans and heat tests may predict migraine in teens